-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II

Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Translational Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, Clinical Research, Pediatric, Supportive Care, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Young adult , Myeloid Malignancies, Survivorship, Study Population, Human, Measurable Residual Disease
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jonatan Källström1,2*, Riitta Niinimäki, PhD3,4*, Johan Fredlund, MD5*, Hartmut Vogt, PhD6,7*, Laura Korhonen, PhD8,9*, Anders Castor, PhD10*, Kjeld Schmiegelow, MD, DMsc11,12, Maria Thastrup, PhD13*, Jonas Abrahamsson, MD, PhD, Professor2,14* and Torben Ek, PhD2,15*

1Children´s Cancer Centre, Queen Silvia Children´S Hospital, Gothenburg, Sweden
2Department of Pediatrics, Institute for Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
3Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland
4Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland
5Department of Pediatrics, Halmstad County Hospital, Halmstad, Sweden
6Crown Princess Victoria Children’s Hospital, Linköping, Sweden
7Department of Biomedical and Clinical Sciences, Division of Children's and Women's Health, Linköping University, Linköping, Sweden
8Department of Pediatrics, University of Turku, Turku, Finland
9Department of Pediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland
10Department of Pediatrics, Skåne University Hospital, Lund University, Lund, Sweden
11Department of Pediatrics and Adolescent Medicine, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
12Medical Faculty, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
13The Laboratory of Pediatric Oncology (Bonkolab), University Hospital Rigshospitalet, Copenhagen, DNK
14Region Vastra Gotaland, Sahlgrenska University Hospital, Gothenburg, Sweden
15Children´s Cancer Centre, Queen Silvia Children´s Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden

Natalie Rafaeli, MD1, David Marin, MD2, Celina Ledesma2*, Nitin Jain, MD3, Priti Tewari, MD4*, Issa F. Khouri, MD2, Amanda L. Olson, MD5, Gheath Alatrash, PhD, DO6, Nicholas J. Short, MD3, Elias Jabbour, MD5, Katy Rezvani, MD7, Amin M. Alousi, MD2*, Uday Popat, MD2, Richard E. Champlin, MD2, Elizabeth J. Shpall, MD2 and Partow Kebriaei, MD1

1MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Pearland, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

Diane Habib, MD1*, Hagop M. Kantarjian, MD2, Fadi G. Haddad, MD3, Nicholas J. Short, MD3, Nitin Jain, MD3, Jayastu Senapati, MD, DM, MBBS3, Kelly S. Chien, MD4, Guillermo Garcia-Manero, MD3, Zena Komrokji5*, Tapan M. Kadia, MD3, Naval Daver, MD6, Courtney D. DiNardo, MD, MSc7, Koji Sasaki, MD3, Rebecca Garris3*, Farhad Ravandi, MBBS8 and Elias Jabbour, MD9

1HCA Houston Healthcare Kingwood, Spring, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson, Houston, TX
5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
6MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Xiaoyuan Gong, MD1,2*, Qiuyun Fang, MD1,2*, Runxia Gu, MD1,2*, Shaowei Qiu, MD1,2*, Kaiqi Liu1,3*, Dong Lin, MD1,2*, Chunlin Zhou, MD1,2*, Shuning Wei1,2*, Guangji Zhang1,2*, Benfa Gong1,2*, Yuntao Liu1,2*, Yan Li, MD1,2*, Shouyun Li, MD1,2*, Bingcheng Liu1,2*, Wang Ying, M.D.1,4*, Hui Wei, MD1,5*, Yingchang Mi, MD1,5 and Jianxiang Wang, MD1,2

1Tianjin Institutes of Health Science, Tianjin, China
2National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
44. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Etan Orgel, MD, MS1, Michael J. Burke, MD2*, John A. Kairalla, PhD3, Emily Hibbitts, PhD3*, Meenakshi Devidas, PhD, MBA4, Michael J. Borowitz, MD, PhD5, Brent L. Wood, MD, PhD6,7, Nyla A. Heerema, PhD8*, Andrew J. Carroll, PhD9, Kelly Maloney, MD10*, Leonard A. Mattano, MD11, Anne Angiolillo, MD12*, Eric C. Larsen, MD13*, Wanda L. Salzer, MD14, David T. Teachey, MD15, Naomi J. Winick, MD16, William L. Carroll, MD17, Stephen P. Hunger, MD18, Elizabeth A. Raetz, MD19 and Mignon L. Loh, MD20

1Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA
2Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
3University of Florida - Children's Oncology Group, Gainesville, FL
4St Jude Children's Research Hospital, Memphis, TN
5Johns Hopkins University School of Medicine, Baltimore, MD
6Keck School of Medicine of University of Southern California, Los Angeles, CA
7Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
8Ohio State University, Columbus, OH
9Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
10Children's Hospital Colorado, Aurora, CO
11HARP Pharma Consulting, LLC, Mystic, CT
12Servier Pharmaceuticals, Boston, MA
13Maine Children's Cancer Program, Scarborough, ME
14U.S. Army Medical Research and Materiel Command, Olney, MD
15Division of Oncology, Children's Hospital of Philadelphia, Rutledge, PA
16Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
17Perlmutter Cancer Center, Department of Pediatrics and Pathology, NYU Grossman School of Medicine, New York, NY
18Division of Oncology, Childrens Hospital of Philadelphia, Philadelphia
19Department of Pediatrics, NYU Langone Health, New York, NY
20Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA

Marion Strullu1*, Arnaud Petit, MD, PhD2,3*, Carine Halfon-Domenech, MD4*, Anne-France Ray-Lunven, MD1*, Paul Saultier5*, Wadih Abou Chahla, MD6*, Stéphane Ducassou7*, Marlène Pasquet, MD8*, Caroline Thomas, MD9*, Cécile Pochon10*, Virginie Gandemer11*, Catherine Paillard, MD, PHD12*, Alexandre Theron, MD13*, Claire Pluchart, MD14*, Pascale Schneider, MD, PhD15*, Damien Bodet16*, Isabelle Pellier, PhD17*, Pierre Simon Rohrlich18*, Anne-France Jourdain19*, Pauline Simon20*, Frederic Millot21*, Liana Carausu22*, Corinne Armari Alla, PhD23*, Camille Leglise24*, Justyna Kanold25*, Claire Desplantes26*, Sandrine Thouvenin27*, Christophe Piguet28*, Nicolas Boissel, MD, PhD29, Wendy Cuccuini, MD, PhD30*, Vahid Asnafi31*, Aurélie Caye-Eude32*, Hélène Cavé, PhD33*, Guy Leverger, MD, PhD34*, Jean-François Benoist35*, Yves Bertrand, MD36*, Sylvie Chevret37* and André Baruchel, MD, PhD38

1Pediatric Hematology, Hopital Robert Debré, AP-HP, Paris, France
2Hôpital Armand Trousseau, APHP, PARIS, Île-de-France, France
3Sorbonne Université, Paris, France
4Institut D'Hématologie Et D'Oncologie Pédiatrique, Lyon, France
5APHM, Marseille, France
6Department of Pediatric Hematology, Centre Hospitalo-Universitaire de Lille, Lille, France
7Service d'onco-hématologie pédiatrique, Hôpital Pellegrin Tripode, Bordeaux, France
8Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France
9Pediatric Oncology, CHU Nantes, Nantes, FRA
10Nancy University Hospital, Pediatric onco-hematology department, Vandoeuvre lès Nancy, France
11Pediatric BMT Unit, Rennes, France
12Pediatric Oncology, CHRU Strasbourg, Strasbourg, FRA
13Pediatric Oncology, CHU Montpellier, Montpellier, FRA
14Pediatric Oncology, CHU de Reims, Reims, France
15Pediatric Hematology, Immunology, Oncology and Stem Cells Transplantation, Rouen University Hospital Charles Nicolle CHU Rouen, Rouen, France
16Pediatric Oncology, CHU De Caen,, Caen, FRA
17Pediatric Oncology, CHU Angers, Angers Cedex, FRA
18Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Nice, Nice, PACA, France
19Pediatric Oncology, CHU de Tours, Tours, France
20Hématologie et oncologie pédiatrique,, CHRU de Besancon, Besancon, France
21Pediatric Oncology, CHU Poitiers, Poitiers, France
22Department of Pediatric Hematology and Oncology,, Centre Hospitalo-Universitaire de Brest, Brest, France, Brest, France
23Pediatric Oncology, CHU Grenoble Hôpital Couple Enfant, GRENOBLE, FRA
24Department of Pediatric Oncology, Hematology, Immunology,, University Hospital of Amiens, Amiens, France
25Pediatric Oncoloy, CHU Clermont Ferrand, Clermontferrand, FRA
26Pediatric Oncology, CHU de Dijon, Dijon, France
27Pediatric Oncology, CHU Saint Etienne, Saint Etienne, FRA
28Pediatric Oncology, CHU Limoges, Limoges, FRA
29Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris Cedex 10, Paris, France
30Saint Louis Hospital, Paris, France
31Hematology Department, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants, Paris, FRA
32Department of Genetics, University Hospital Robert Debré, Assistance Publique Des Hôpitaux, Paris, France
33Department of Genetics, Hôpital Robert Debré, Paris, France
34Pediatric Hematology Oncology Immunology Department, Hôpital Trousseau, Paris, France
35Biochemistry Department, Hôpital Universitaire Necker Enfants Malades, Paris, France
36Pediatric Hematology, Institut d'Hématologie et Oncologie Pédiatrique, Lyon, France
37Biostatistics and Medical Information Department, Saint Louis Hospital, Assistance Publique — Hôpitaux de Paris (AP-HP), Paris, France
38Department of Pediatric Hematology and Immunology,, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France

Lijuan Hu1*, Ya-Zhe Wang2*, Xiang Wang2*, Zongru Li, MD2*, Ting Zhao3*, Wenbing Duan4*, Lu Yu5* and Qian Jiang, MD6

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Bejing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease, China, Beijing, China
4Department of Hematology, Peking University People's Hospital, Beijing, China
5National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
6National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China

Angus Hodder, MBBS1,2*, Avijeet Kumar Mishra, MD, MBBS3*, Philip Connor4*, Michelle Cummins5*, Danny Cheng, MA, MBBS, MRCP1*, Michael Gattens6*, Brenda Gibson, MD7*, Danielle Ingham8*, Katherine Lindsay9*, Andrea Malone, MD10*, Majid Madni11*, John Moppett12*, Jayashree Motwani13*, Pritesh Patel14*, Subramaniam Ramanathan, MD, DM15*, Anindita Roy, MD, PhD16, Beki James, MD17*, Phil Ancliff1*, Ajay Vora1 and Jack Bartram1*

1Great Ormond Street Hospital for Children, London, United Kingdom
2Wellcome Sanger Institute, London, United Kingdom
3Cincinnati Children's Hospital, Cincinnati, OH
4Children's Hospital For Wales, Cardiff, GBR
5Bristol Royal Hospital For Children, Bristol, GBR
6Addenbrookes Hospital, Cambridge, Cambridge, GBR
7Department of Paediatric Haematology, Royal Hospital for Sick Children, Glasgow, United Kingdom
8Leeds Children's Hospital, Leeds, GBR
9Alder Hey Children's Hospital, Liverpool, United Kingdom
10Children’s Health Ireland, Dublin, IRL
11Department of paediatric haematology and oncology, Nottingham University Hospitals, Nottingham, United Kingdom
12Bristol Royal Hospital For Sick Children, Bristol, GBR
13Birmingham Children's Hospital, Birmingham, GBR
14Great Ormond Street Hospital, London, United Kingdom
15Newcastle Upon Tyne NHS Foundation Trust, Newcastle Upon Tyne, ENG, GBR
16Department of Paediatrics, University of Oxford, Oxford, United Kingdom
17Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom

Xiaopei Lily Zeng, MD1,2, Soyang Kwon, PhD2,3*, Anant Vatsayan, MBBS4, Christina Baggott, PhD5*, Snehit Prabhu, PhD6*, Samuel John, MD7*, Holly L. Pacenta, MD8*, Christine L. Phillips, MD9,10, Jenna Rossoff, MD1,2, Julie-An Talano, MD11, Amy Moskop, MD11, Michael R Verneris, MD12, Douglas D. Myers, MD13*, Erin Marie Hall, MD13*, Nicole A Karras, MD14*, Challice L. Bonifant, MD, PhD15, Muna Qayed, MD16,17, Michelle L. Hermiston, MD, PhD18, Prakash Satwani, MD, MBBS19, Christa Krupski, DO, MPH10,20*, Amy K Keating, MD21,22,23*, Susanne H.C. Baumeister, MD21,22,23, Vanessa A. Fabrizio, MD12, Vasant Chinnabhandar, MD, MBBS24*, Emily Egeler6*, Sharon Mavroukakis, MS6*, Khanh Nguyen6*, Kevin J. Curran, MD25,26*, Crystal L. Mackall, MD5,6,27, Theodore W. Laetsch, MD28,29*, Liora Michal Schultz, M.D.5 and Kevin O. McNerney, MD, MSc1,2

1Division of Hematology, Oncology, Neuro-oncology, and Stem Cell Transplant, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
2Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
3Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
4Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC
5Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
6Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
7Department of Pediatrics, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX
8Cook Children's Hospital, Fort Worth, TX
9Cancer and Blood Diseases Institute, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
10Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
11Department of Pediatrics, Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI
12Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO
13Department of Hematology, Oncology and Blood and Marrow Transplantation, Children's Mercy Hospital, University of Missouri Kansas City, Kansas City, MO
14Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
15Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
16Emory University, Winship Cancer Institute, Atlanta, GA
17Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
18Department of Pediatric, Division of Pediatric Hematology-Oncology, University of California San Francisco, Benioff Children’s Hospital, San Francisco, CA
19Department of Pediatrics, Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
20Cancer and Blood Disease Institute, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
21Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA
22Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
23Department of Pediatrics, Harvard Medical School, Boston, MA
24Department of Pediatric Oncology, Hematology, Blood and Marrow Transplantation, Perth Children's Hospital, Nedlands, Australia
25Department of Pediatrics, Weill Cornell Medical College, New York, NY
26Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
27Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
28Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
29Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Tingting Yang1,2,3*, Yetian Dong1,2,3*, Mingming Zhang2,3,4*, Jingjing Feng1,2,3*, Shan Fu2,3,5*, Pingnan Xiao1,2,3*, Ruimin Hong2,3,5*, Huijun Xu2,3,6*, Jiazhen Cui1,2,3*, Simao Huang1,2,3*, Guoqing Wei1,2,3*, Alex H. Chang7*, He Huang, MD1,2,8* and Yongxian Hu1,2,3*

1Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2Institute of Hematology, Zhejiang University, Hangzhou, China
3Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
4Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
5Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
7Shanghai YaKe Biotechnology Ltd, Shanghai, China
8Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, hangzhou, China

Yoshihiro Hatta, MD1, Fumihiko Hayakawa, MD2, Etsuko Yamazaki, MD3, Tohru Murayama, MD, PhD4*, Takeshi Saito, MD5, Masatsugu Tanaka, MD6*, Noriko Doki7, Tetsuya Nishida, MD PhD8*, Yuna Katsuoka, MD9*, Satoru Takada, MD10*, Tatsuhiro Sakamoto, MD, PhD11*, Shinya Sato, MD12*, Yoshiko Atsuta, MD, PhD13*, Shigeki Ohtake, MD14*, Emiko Sakaida, MD PhD15, Yoshinobu Maeda, MD, PhD16, Takahiro Yamauchi, MD17, Itaru Matsumura, MD18, Yasushi Miyazaki, MD, PhD19 and Hitoshi Kiyoi, MD PhD20

1Department of Medicine Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
2Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, JPN
3Dept. Hematology, Yokohama Rosai Hospital, Yokohama, Japan
4Dept. Hematology, Hyogo Cancer Center, Akashi, Japan
5Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
6Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
9National Hospital Organization Sendai Medical Center, Sendai, JPN
10Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
11Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
12Department of Hematology, Nagasaki University Hospital, Nagasaki, JPN
13Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
14Kanazawa University, Kanazawa, Japan
15Department of Hematology, Chiba University Hospital, Chiba City, Japan
16Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
17Department of Hematology and Oncology, University of Fukui, Fukui, Japan
18Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
19Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
20Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Katherine Tobon, PharmD, BS1*, Kylie Consalvo, PharmD2*, Syeda Saba Kareem, PharmD1*, Jeffrey E Lancet, MD1, Rami S. Komrokji, MD1, Javier Pinilla-Ibarz, MD, PhD3, David Sallman, MD1, Jennifer Eatrides, MD4*, Alison R. Walker, MD, MBA, MPH1, Julio C. Chavez, MD1, Leidy L. Isenalumhe, MD, MS1 and Bijal D Shah, MD1

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2Moffitt Cancer Center, Tampa
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Community and Satellite Oncology, Moffitt Cancer Center, Tampa, FL

Elias Jabbour, MD1, Hagop M. Kantarjian, MD1, Ibrahim Aldoss, MD2, Pau Montesinos, PhD, MD3*, Jessica T. Leonard, MD4, David Gomez-Almaguer, MD5, Maria R. Baer, MD6, Carlo Gambacorti-Passerini, MD, Prof.7, James McCloskey, MD8, Yosuke Minami, MD, PhD9, Cristina Papayannidis, MD, PhD10*, Vanderson Rocha, MD, PhD, MS11*, Philippe Rousselot, MD PhD12*, Pankit Vachhani, MD13*, Eunice S. Wang, MD14, Lin Yang, PhD, MSc15*, Meliessa Hennessy, MPH15*, Alexander Vorog, MD15*, Niti Patel, PhD15*, Tammie Yeh, PhD15* and Josep-Maria Ribera, MD, PhD16

1The University of Texas MD Anderson Cancer Center, Houston, TX
2City of Hope – Duarte, Duarte, CA
3Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
4Oregon Health and Science University, Portland, OR
5Hospital Universitario, UANL; Dr. José Eleuterio Gonzalez, Monterrey, Mexico
6University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
7University Milano-Bicocca, Monza, Italy
8Hackensack University Medical Center, Hackensack, NJ
9National Cancer Center Hospital East, Kashiwa, Japan
10IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy
11Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil
12Hospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France
13University of Alabama at Birmingham, Birmingham, AL
14Roswell Park Comprehensive Cancer Center, Leukemia Service, Buffalo, NY
15Takeda Development Center Americas, Inc., Cambridge, MA
16ICO-Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

Qingsong Yin, PhD1*, Taotao Liang2,3*, Shan Wang2*, Yuqing Chen4*, Wenli Zuo2*, Qinglan Zhang2*, Hongxia Ma5*, Hao Ai2*, Qian Wang1* and Hongfei Wu2*

1Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
2Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
3Henan Cancer Hospital, Zhengzhou, China
4Department of Hematology, Henan Province People's Hospital, Zhengzhou, China
5The third people's hospital of zhengzhou city, Zhengzhou, China

Anna Z Castleton1*, Michelle Lannon, MBBS, MRCP, FRCPath2*, Ned Atiyah, BSc (Hons) Biomed Sci, MA Public Health3*, Alexandra Smith, PhD3*, Lindsay George, PhD, FRCPath4*, Sridhar Chaganti, MD, PhD, FRCPath, MRCP4*, Eleni Tholouli, MD, PhD, FRCPath5*, Pakhshan Farshi, MD5*, Nicholas Cunningham, MD, BSc, FRCPath6*, Claire Arnold6*, Nick Morley7*, Philippa Kelsey, MBChB MRCP FRCPath7*, Prudence Hardefeldt, MBBS (hons), MPhil, FRACP, FRCPA8*, Katja Kimberger9*, Manish Jain, FRCPath, MBBS10*, Maeve O'Reilly11*, Richard Burt, PhD, FRCPath, MRCP12*, Tobias Menne, PhD2*, Ahmed Abdulgawad, MSc, PhD, MRCP, FRCPath1*, Katharine Hodby, BMCh(Ox), FRCPath13*, Aniruddha Dayama, MD13*, David A. Irvine, PhD, FRCPath, MRCP14, Anne Louise Latif14*, Deborah Susan Richardson, MD, FRCP, FRCPath, MA, MBBChir15, Mariam Amer16*, Ram Malladi, MD, PhD17*, James Aries, MBChB, MRCP, FRCPath, PhD18*, Seda Cakmak18*, Johannes De Vos18*, Gerardo Errico19*, Emma Nicholson, MD20*, Kirsty Marie Sharplin, MBBS21*, Andrew Peniket21*, Bela Patel Wrench, MDRes22*, Anthony Moorman23*, Clare Rowntree24*, David Marks25*, Adele Fielding26* and Deborah Yallop, MD, PhD27*

1The Christie NHS Foundation Trust, Manchester, United Kingdom
2Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
3Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom
4University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
5Manchester Royal Infirmary, Manchester, United Kingdom
6Belfast City Hospital, Belfast, United Kingdom
7Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
8King's College Hospital NHS Foundation Trust, London, United Kingdom
9Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
10Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
11Department of Hematology, University College London Hospitals, London, United Kingdom
12University College London Hospitals, London, United Kingdom
13University Hospitals Bristol NHS Trust, Bristol, United Kingdom
14Queen Elizabeth University Hospital, Glasgow, United Kingdom
15University Hospitals Southampton, Southampton, United Kingdom
16University Hospital Southampton, Southampton, United Kingdom
17Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
18Barts Health NHS Trust, London, United Kingdom
19Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
20Royal Marsden NHS Foundation Trust, London, United Kingdom
21Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
22Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
23Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
24University Hospital of Wales, Cardiff, United Kingdom
25Department of Hematology, University Hospitals Bristol, Bristol, United Kingdom
26University of York, York, United Kingdom
27King’s College Hospital, London, United Kingdom

Changwen Xue1,2*, Yingjin Zhang1,3*, Chao Wu1,3*, Wenyu Yang1,3*, Yao Zou1,4*, Ye Guo1,5*, Yumei Chen1,5*, Xiaojuan Chen, MD1,5*, Yueshen Ma1,3*, Xiaofan Zhu, MD1,4 and Li Zhang1,3*

1Tianjin Institutes of Health Science, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Cent, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
5Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China

Ajibade Ashaye, MD, MS, MBA, MPH1, Ling Shi, PhD2*, Ibrahim Aldoss, MD3, Pau Montesinos, PhD, MD4*, Pankit Vachhani, MD5*, Cristina Papayannidis, MD, PhD6, Jessica T. Leonard, MD7, Maria R. Baer, MD8, Josep-Maria Ribera, MD, PhD9, James McCloskey, MD10, Jianxiang Wang, MD11, Sujun Gao12*, Deepali Rane, MBBS, MPH1* and Shien Guo, PhD2*

1Takeda Development Center Americas, Inc., Cambridge, MA
2Evidera Inc., Bethesda, MD
3City of Hope National Medical Center, Duarte, CA
4Hospital Universitari i Politècnic La Fe, Valencia, Spain
5University of Alabama at Birmingham, Birmingham, AL
6IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “L. e A. Seràgnoli”, Bologna, Italy
7Oregon Health and Science University, Portland, OR
8University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
9ICO – Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain
10Hackensack University Medical Center, Hackensack, NJ
11Institute of Hematology & Blood Diseases Hospital of CAMS & PUMC, Tianjin, China
12The First Hospital of Jilin University, Changchun, China

Macarena Ottobre, MD1*, Laura Colitto2*, Maria Ines Marcone3*, Eliana Krystal2*, Lorena Moran, MD4*, Laureana Eleonora Wittmund, MD2*, Vanesa Gimenez, MD5* and Monica Makiya6*

1Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, Argentina
2Hospital de Niños Dr. Ricardo Gutiérrez, CABA, Argentina
3Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, BA, Argentina
4Hospital De Niños R. Gutiérrez, Hematology and Oncology Department, CABA, Argentina
5Hospital Interzonal de Agudos Especializado en Pediatría Sor María Ludovica, La Plata, ARG
6Hospital Italiano de Buenos Aires, Buenos Aires, BA, Argentina

Francesca Del Bufalo, MD, PhD1*, Andrej Lissat, MD, PhD2*, Chiara Rosignoli, MD1*, Veerle Mondelaers, MD3*, Christophe Chantrain, MD, PhD4*, Jochen Büchner, MD, PhD5*, Roberto Carta, MD1*, Marco Becilli, MD1*, Jonas Eggeling, MD2*, Federica Galaverna, MD, PhD1*, Stefania Gaspari, MD1*, Maria Giuseppina Cefalo, MD1*, Arend von Stackelberg, MD2* and Franco Locatelli, MD1,6

1Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
2Department of Hematology and Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany
3Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, UZ GENT, Ghent, BEL
4Division of Pediatric Hematology-Oncology, Centre Hospitalier Chrétien (CHC), MontLégia, Liege, Belgium
5Oslo University Hospital, Oslo, Norway
6Catholic University of the Sacred Heart, Rome, Italy

Tingting Zhang*, Li Liu, MD*, Xiaohui Zheng*, Biao Shen*, Ming Gong*, Xin Liu*, Gang Li*, Ying Zhang*, Wenbin Cao*, Chen Liang*, Aiming Pang*, Yi He*, Donglin Yang*, Sizhou Feng*, Mingzhe Han* and Erlie Jiang*

Institute of Haematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Etan Orgel, MD, MS1,2, Sarah K Tasian, MD3, Yueh-Yun Chi, PhD4,5*, Jemily Malvar, MS6*, Christina M. Dieli-Conwright7*, Rubi Buxton8*, Mackenzie Frederick, RD9*, Hannah Williams10*, Karen R Rabin, MD, PhD11, Susan R Rheingold, MD12, Robin Norris, MD, MS, MPH13, Tamara P. Miller, MD14, Brent L. Wood, MD, PhD5,15, Ellynore Florendo8*, Ellen Chang, MD16*, Lisa Hartman17*, Mallorie M. Heneghan, MD18, Michelle L. Hermiston, MD, PhD19, Joel Kaplan, DO20*, Tamra Slone, MD21*, Deepa Bhojwani, MD22, Alan S. Wayne, MD23 and Steven D. Mittelman24*

1Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA
2Keck School of Medicine of Medicine, University of Southern California, Los Angeles, CA
3Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
4Biostatistics, Children's Hospital of Los Angeles, Los Angeles, CA
5Keck School of Medicine of University of Southern California, Los Angeles, CA
6Biostatistics, Children's Hospital Los Angeles, Los Angeles, CA
7Dana Farber Cancer Institute, Boston
8Childrens Hospital Los Angeles, Los Angeles, CA
9Texas Children's Cancer and Hematology Centers, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
10Children's Hospital of Philadelphia, Philadelphia, PA
11Department of Pediatrics, Baylor College of Medicine TX Children's Cancer Center, Houston, TX
12Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
13Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
14Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Decatur, GA
15Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
16Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
17University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO
18Ann & Robert Lurie Children's Hospital, Salt Lake City, UT
19Department of Pediatric, Division of Pediatric Hematology-Oncology, University of California San Francisco, Benioff Children’s Hospital, San Francisco, CA
20Levine Children's Hosp. at Carolinas Med. Ctr., Charlotte, NC
21Univ. of TX, Southwestern, Dallas, TX
22Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
23Children's Hospital of Los Angeles, Los Angeles, CA
24University California- Los Angeles, Los Angeles, CA

*signifies non-member of ASH